VBL Therapeutics to Present at the Piper Jaffray 30th Annual Healthcare Conference on November 28
Presentation Details: | ||
Date: Time: Location: Webcast: |
Wednesday, November 28 3:30-3:55 PM Eastern Time SoHo Track - Hubbard 1, 5th floor https://event.webcasts.com/starthere.jsp?ei=1220342&tp_key=0f7f922eb8 |
|
About VBL
Forward Looking Statements
This press release contains forward-looking statements. All statements other than statements of historical fact are forward-looking statements, which are often indicated by terms such as “anticipate,” “believe,” “could,” “estimate,” “expect,” “goal,” “intend,” “look forward to”, “may,” “plan,” “potential,” “predict,” “project,” “should,” “will,” “would” and similar expressions. These forward-looking statements include, but are not limited to, statements regarding our programs, including VB-111, including their clinical development, therapeutic potential and clinical results. These forward-looking statements are not promises or guarantees and involve substantial risks and uncertainties. Among the factors that could cause actual results to differ materially from those described or projected herein include uncertainties associated generally with research and development, clinical trials and related regulatory reviews and approvals, the risk that historical clinical trial results may not be predictive of future trial results, and that we may not realize the expected benefits of our intellectual property protection. A further list and description of these risks, uncertainties and other risks can be found in the Company’s regulatory filings with the
INVESTOR CONTACT:
LifeSci Advisors, LLC
(646) 597-6979